Robert Ang
President and CEO at Vor Biopharma Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Vor Biopharma Inc., 3 years.
Vor Biopharma Inc.
Director · PRESIDENT AND CEO
Chief executive roles
Vor Biopharma Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 6, 2024 | Vor Biopharma Inc. | Shares withheld for tax | −2,361 | $1.75 | $4,132 |
| May 1, 2024 | Vor Biopharma Inc. | Shares withheld for tax | −2,751 | $1.77 | $4,869 |
| Mar 1, 2024 | Vor Biopharma Inc. | Shares withheld for tax | −12,657 | $2.27 | $28,731 |
| Feb 6, 2024 | Vor Biopharma Inc. | Shares withheld for tax | −2,788 | $2.32 | $6,468 |
| Jan 29, 2024 | Vor Biopharma Inc. | Grant or award | +150,000 | — | — |
| Nov 6, 2023 | Vor Biopharma Inc. | Shares withheld for tax | −2,361 | $1.82 | $4,297 |
| Sep 1, 2023 | Vor Biopharma Inc. | Shares withheld for tax | −12,657 | $2.67 | $33,794 |
| Aug 7, 2023 | Vor Biopharma Inc. | Shares withheld for tax | −2,361 | $2.67 | $6,304 |
| May 8, 2023 | Vor Biopharma Inc. | Shares withheld for tax | −2,361 | $4.14 | $9,775 |
| Mar 1, 2023 | Vor Biopharma Inc. | Shares withheld for tax | −12,657 | $5.51 | $69,740 |
| Feb 6, 2023 | Vor Biopharma Inc. | Grant or award | +128,750 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.